Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizPatent reform will pass soon [?]
By Lawrence B. Ebert, Esq.
High tech companies and drug companies agree that U.S. patent reform will pass soon, but there is considerably less agreement on what it should look like.
As might be expected, the significant disagreement concerns a money issue:
Tom DiLenge, general counsel for the Biotechnology Industry Organization, has called calculating damages for infringement "the toughest nut to crack."
The article even quoted a pharma person as seeing a consensus coming:
Philip Johnson, chief patent counsel for Johnson & Johnson, predicted the two sides would get a consensus on the bill, despite the widely differing interests involved.
Full post as published by IPBiz on February 08, 2008 (boomark / email).
The S Corporation
Avoiding double taxation
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Texas, USA
alleging the Medical Malpractice and Tort Reform Act of 2003 violates several provisions of the Constitution.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
Tollway I-Pass
alleging that users were sent erroneous fines
Clear
Verified Identity Pass Face Class Action
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.

Patently-O Bits and Bytes No. 56
Patent Reform Predictions and More
White House Opposes Patent Reform Acts Limit on Damage Calculations
Vote on Patent Reform Delayed; Senators Remain Optimistic








